Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Evotec AG Total Long-Term Assets 2010-2024 | EVO

Evotec AG total long-term assets from 2010 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current
  
Evotec AG Annual Total Long-Term Assets
(Millions of US $)
2023 $1,460
2022 $1,247
2021 $1,342
2020 $918
2019 $797
2018 $617
2017 $550
2016 $202
2015 $135
2014 $132
2013 $139
2012 $177
2011 $188
2010 $
2009 $108
Evotec AG Quarterly Total Long-Term Assets
(Millions of US $)
2024-09-30 $1,421
2024-06-30 $1,447
2024-03-31 $1,501
2023-09-30 $1,432
2023-06-30 $1,390
2022-12-31 $1,247
2022-09-30 $1,175
2022-06-30 $1,223
2022-03-31 $1,261
2021-12-31 $1,342
2021-09-30 $1,344
2021-06-30 $1,188
2021-03-31 $1,085
2020-12-31 $918
2020-09-30 $868
2020-06-30 $820
2020-03-31 $793
2019-12-31 $797
2019-09-30 $749
2019-06-30 $678
2019-03-31 $711
2018-12-31 $617
2018-09-30 $577
2018-06-30 $580
2018-03-31 $602
2017-12-31 $550
2017-09-30 $540
2017-06-30 $207
2017-03-31 $198
2016-12-31 $202
2016-09-30 $130
2016-06-30 $132
2016-03-31 $128
2015-12-31 $135
2015-09-30 $126
2015-06-30 $87
2015-03-31 $88
2014-12-31 $100
2014-09-30 $100
2014-06-30 $114
2014-03-31 $109
2013-12-31 $107
2013-09-30 $141
2013-06-30 $143
2013-03-31 $147
2012-12-31 $142
2012-09-30 $146
2012-06-30 $147
2012-03-31 $143
2011-12-31 $153
2011-09-30 $162
2011-06-30 $157
2011-03-31 $117
2010-12-31
2010-09-30 $101
2010-06-30 $65
2010-03-31 $82
2009-12-31 $82
2009-09-30 $96
2009-06-30 $92
2009-03-31 $88
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.456B $0.846B
EVOTEC is a leader in the discovery and development of novel small molecule drugs. They have established a powerful platform that is applicable to targets across all therapeutic areas and has specific expertise in the area of Central Nervous System related diseases where it is building a pipeline of drug candidates for partnering. Through research collaborations and proprietary projects They are providing the highest quality research results to its partners in the pharmaceutical and biotechnology industries
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $74.844B 28.80
Chugai Pharmaceutical (CHGCY) Japan $70.231B 27.36
Takeda Pharmaceutical (TAK) Japan $41.110B 8.56
Sandoz Group AG (SDZNY) Switzerland $19.633B 0.00
Merck (MKKGY) Germany $18.831B 16.86
Astellas Pharma (ALPMY) Japan $17.264B 15.90
United Therapeutics (UTHR) United States $16.024B 15.76
Neurocrine Biosciences (NBIX) United States $14.505B 38.41
Summit Therapeutics (SMMT) United States $14.034B 0.00
Shionogi (SGIOY) Japan $12.114B 12.14
Orion OYJ (ORINY) Finland $7.195B 20.23
Stevanato Group S.p.A (STVN) Italy $6.920B 44.80
Madrigal Pharmaceuticals (MDGL) United States $6.404B 0.00
Corcept Therapeutics (CORT) United States $5.795B 43.90
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.456B 0.00
Grifols, S.A (GRFS) Spain $4.999B 0.00
Ionis Pharmaceuticals (IONS) United States $4.963B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.464B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.717B 12.31
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.559B 15.30
Recursion Pharmaceuticals (RXRX) United States $2.551B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.176B 0.00
Soleno Therapeutics (SLNO) United States $2.021B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.999B 0.00
Hypermarcas (HYPMY) Brazil $1.932B 0.00
Indivior (INDV) United States $1.606B 6.54
BioCryst Pharmaceuticals (BCRX) United States $1.543B 0.00
Dyne Therapeutics (DYN) United States $1.438B 0.00
Xencor (XNCR) United States $1.346B 0.00
Guardian Pharmacy Services (GRDN) United States $1.310B 0.00
Ocular Therapeutix (OCUL) United States $1.259B 0.00
ARS Pharmaceuticals (SPRY) United States $1.222B 0.00
Harrow (HROW) United States $1.206B 0.00
Ardelyx (ARDX) United States $1.187B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.147B 0.00
Collegium Pharmaceutical (COLL) United States $1.076B 5.87
Enliven Therapeutics (ELVN) United States $1.049B 0.00
Bioventus (BVS) United States $0.815B 25.74
Cronos Group (CRON) Canada $0.761B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.747B 0.00
Relay Therapeutics (RLAY) United States $0.747B 0.00
USANA Health Sciences (USNA) United States $0.648B 12.02
Ironwood Pharmaceuticals (IRWD) United States $0.586B 0.00
Elite Pharmaceuticals (ELTP) United States $0.526B 0.00
Verve Therapeutics (VERV) United States $0.520B 0.00
Savara (SVRA) United States $0.503B 0.00
Altimmune (ALT) United States $0.488B 0.00
ProKidney (PROK) United States $0.484B 0.00
Xeris Biopharma Holdings (XERS) United States $0.477B 0.00
Tourmaline Bio (TRML) United States $0.462B 0.00
OmniAb (OABI) United States $0.453B 0.00
Akebia Therapeutics (AKBA) United States $0.452B 0.00
Siga Technologies (SIGA) United States $0.444B 5.19
Esperion Therapeutics (ESPR) United States $0.435B 0.00
Zevra Therapeutics (ZVRA) United States $0.430B 0.00
Oruka Therapeutics (ORKA) United States $0.429B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.422B 0.00
Organogenesis (ORGO) United States $0.420B 0.00
KalVista Pharmaceuticals (KALV) United States $0.410B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.355B 143.79
Korro Bio (KRRO) United States $0.347B 0.00
Aldeyra Therapeutics (ALDX) United States $0.288B 0.00
Aquestive Therapeutics (AQST) United States $0.283B 0.00
Nature's Sunshine Products (NATR) United States $0.264B 15.68
Heron Therapeutics (HRTX) United States $0.248B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.247B 0.00
Avita Medical (RCEL) United States $0.227B 0.00
Profound Medical (PROF) Canada $0.221B 0.00
Larimar Therapeutics (LRMR) United States $0.213B 0.00
4D Molecular Therapeutics (FDMT) United States $0.212B 0.00
MediWound (MDWD) Israel $0.190B 0.00
Inhibikase Therapeutics (IKT) United States $0.189B 0.00
CytoDyn (CYDY) United States $0.185B 0.00
Aclaris Therapeutics (ACRS) United States $0.184B 0.00
Acrivon Therapeutics (ACRV) United States $0.180B 0.00
VAXART, INC (VXRT) United States $0.168B 0.00
Lyell Immunopharma (LYEL) United States $0.168B 0.00
Lexeo Therapeutics (LXEO) United States $0.168B 0.00
Nektar Therapeutics (NKTR) United States $0.165B 0.00
Silence Therapeutics (SLN) United Kingdom $0.153B 0.00
Jupiter Neurosciences (JUNS) United States $0.146B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.145B 0.00
Nanobiotix S.A (NBTX) France $0.143B 0.00
Telomir Pharmaceuticals (TELO) United States $0.139B 0.00
Champions Oncology (CSBR) United States $0.135B 0.00
Cassava Sciences (SAVA) United States $0.132B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.111B 0.00
Inotiv (NOTV) United States $0.111B 0.00
Achieve Life Sciences (ACHV) Canada $0.106B 0.00
ElectroCore (ECOR) United States $0.104B 0.00
Cardiol Therapeutics (CRDL) Canada $0.099B 0.00
Metagenomi (MGX) United States $0.098B 0.00
Protara Therapeutics (TARA) United States $0.094B 0.00
Pyxis Oncology (PYXS) United States $0.089B 0.00
Fractyl Health (GUTS) United States $0.087B 0.00
Arch Biopartners (ACHFF) Canada $0.085B 0.00
Karyopharm Therapeutics (KPTI) United States $0.083B 0.00
Regulus Therapeutics (RGLS) United States $0.081B 0.00
Assertio Holdings (ASRT) United States $0.079B 20.68
Galectin Therapeutics (GALT) United States $0.078B 0.00
ESSA Pharma (EPIX) Canada $0.078B 0.00
Century Therapeutics (IPSC) United States $0.077B 0.00
Journey Medical (DERM) United States $0.076B 0.00
Context Therapeutics (CNTX) United States $0.076B 0.00
Vivani Medical (VANI) United States $0.071B 0.00
PMV Pharmaceuticals (PMVP) United States $0.071B 0.00
Avalo Therapeutics (AVTX) United States $0.070B 0.00
Mural Oncology (MURA) Ireland $0.068B 0.00
AleAnna (ANNA) United States $0.065B 0.00
Unicycive Therapeutics (UNCY) United States $0.064B 0.00
OptiNose (OPTN) United States $0.064B 0.00
Gain Therapeutics (GANX) United States $0.060B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.059B 0.00
Prelude Therapeutics (PRLD) United States $0.058B 0.00
FibroGen (FGEN) United States $0.058B 0.00
Rafael Holdings (RFL) United States $0.050B 0.00
NRx Pharmaceuticals (NRXP) United States $0.049B 0.00
AlloVir (ALVR) United States $0.047B 0.00
Nutriband (NTRB) United States $0.046B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.044B 0.00
SCYNEXIS (SCYX) United States $0.043B 0.00
Iterum Therapeutics (ITRM) Ireland $0.042B 0.00
CASI Pharmaceuticals (CASI) China $0.041B 0.00
Scienture Holdings (SCNX) United States $0.040B 0.00
Tempest Therapeutics (TPST) United States $0.040B 0.00
VYNE Therapeutics (VYNE) United States $0.040B 0.00
BioVie (BIVI) United States $0.040B 0.00
Surrozen (SRZN) United States $0.039B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.036B 0.00
Incannex Healthcare (IXHL) Australia $0.034B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.031B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.030B 0.00
Citius Pharmaceuticals (CTXR) United States $0.028B 0.00
Vivos Therapeutics (VVOS) United States $0.028B 0.00
DURECT (DRRX) United States $0.026B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.026B 0.00
Natural Alternatives (NAII) United States $0.026B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Lipocine (LPCN) United States $0.023B 0.00
Traws Pharma (TRAW) United States $0.022B 0.00
Mannatech (MTEX) United States $0.021B 0.00
Cosmos Health (COSM) United States $0.020B 0.00
MEI Pharma (MEIP) United States $0.019B 0.00
Carisma Therapeutics (CARM) United States $0.018B 0.00
GlycoMimetics (GLYC) United States $0.017B 0.00
PolyPid (PYPD) Israel $0.016B 0.00
Minerva Neurosciences (NERV) United States $0.016B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
TherapeuticsMD (TXMD) United States $0.012B 0.00
Biomerica (BMRA) United States $0.012B 0.00
Nuvilex (PMCB) United States $0.012B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.012B 0.00
Talphera (TLPH) United States $0.011B 0.00
Relmada Therapeutics (RLMD) United States $0.011B 0.00
Jaguar Animal Health (JAGX) United States $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.009B 0.00
Ainos (AIMD) United States $0.009B 0.00
Klotho Neurosciences (KLTO) United States $0.009B 0.00
Indaptus Therapeutics (INDP) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
BioLineRx (BLRX) Israel $0.008B 0.00
Dominari Holdings (DOMH) United States $0.008B 0.00
Conduit Pharmaceuticals (CDT) United States $0.007B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.007B 0.00
Redhill Biopharma (RDHL) Israel $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Viracta Therapeutics (VIRX) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
SciSparc (SPRC) Israel $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Phio Pharmaceuticals (PHIO) United States $0.004B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.10
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
Bio-Path Holdings (BPTH) United States $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
SHINECO (SISI) China $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Clearmind Medicine (CMND) Canada $0.003B 0.00
TransCode Therapeutics (RNAZ) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00